Provided by Tiger Trade Technology Pte. Ltd.

Pliant Therapeutics, Inc.

1.17
-0.0600-4.88%
Post-market: 1.16-0.0085-0.73%18:36 EDT
Volume:726.68K
Turnover:863.64K
Market Cap:72.44M
PE:-0.48
High:1.26
Open:1.24
Low:1.15
Close:1.23
52wk High:1.95
52wk Low:1.09
Shares:61.91M
Float Shares:55.57M
Volume Ratio:1.79
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4336
EPS(LYR):-2.4336
ROE:-61.55%
ROA:-30.15%
PB:0.40
PE(LYR):-0.48

Loading ...

Nov 09, 2021

Major Issues Report

8-K - Current report
Sep 07, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 02, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Mar 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2021

Major Issues Report

8-K - Current report
Dec 21, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Major Issues Report

8-K - Current report
Aug 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]